During menopause, estrogen deficiency decreases the OPG level with a relative increase in RANKL activity, which explains the sharp acceleration of bone loss in women after the age of 50 and the development of postmenopausal osteoporosis. This evidence concerns the gene TNFRSF11B and postmenopausal osteoporosis.